GIMONDI, SILVIA ALESSANDRA
GIMONDI, SILVIA ALESSANDRA
Dipartimento di Oncologia ed Emato-Oncologia
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
2018 N. Bolli, G. Biancon, M. Moarii, S. Gimondi, Y. Li, C. de Philippis, F. Maura, V. Sathiaseelan, Y. Tai, L. Mudie, S. O’Meara, K. Raine, J.W. Teague, A.P. Butler, C. Carniti, M. Gerstung, T. Bagratuni, E. Kastritis, M. Dimopoulos, P. Corradini, K.C. Anderson, P. Moreau, S. Minvielle, P.J. Campbell, E. Papaemmanuil, H. Avet-Loiseau, N.C. Munshi
Non-invasive molecular monitoring in multiple myeloma patients using cell-free tumor DNA: a pilot study
2018 G. Biancon, S. Gimondi, A. Vendramin, C. Carniti, P. Corradini
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases
2017 D. Baratti, S. Kusamura, D. Iusco, S. Gimondi, F. Pietrantonio, M. Milione, M. Guaglio, S. Bonomi, A. Grassi, S. Virzì, E. Leo, M. Deraco
A novel in-house deep sequencing method for non-invasive disease monitoring in multiple myeloma patients
2017 C. Carniti, G. Biancon, S. Gimondi, A. Vendramin, A. Bermema, S. Rizzitano, M. Magni, N. Bolli, V. Montefusco, P. Corradini
Analysis of the genomic lanscape of multiple myeloma highlights novel candidate prognostic markers and disease subgroups
2017 N. Bolli, G. Biancon, M. Moarii, S. Gimondi, Y. Li, C. De Philippis, F. Maura, V. Sathiaseelan, T. Yu-Tzu, L. Mudie, S. O’Meara, K. Raine, J.W. Teague, A.P. Butler, C. Carniti, M. Gerstung, T. Bagratuni, E. Kastritis, M.A. Dimopoulos, P. Corradini, K.C. Anderson, P. Moreau, S. Minvielle, P.J. Campbell, E. Papaemmanuil, H. Avet-Loiseau, N.C. Munshi
A targeted sequencing approach in multiple myeloma reveals a complex landscape of genomic lesions that has implications for prognosis
2016 N. Bolli, G. Biancon, S. Gimondi, Y. Li, V. Sathiaseelan, F. Maura, C. Carniti, M. Fulciniti, R. Szalat, K. Anderson, S. Minvielle, M. Attal, P. Moreau, P. Campbell, H. Avet-Loiseau, N. Munshi
Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation
2016 S. Gimondi, M. Dugo, A. Vendramin, A. Bermema, G. Biancon, A. Cavané, P. Corradini, C. Carniti
Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements
2016 S. Gimondi, G. Biancon, A. Vendramin, S. Zaninelli, S. Rizzitano, S.C. Malan, A. Bermema, V. Montefusco, C. Carniti, P. Corradini
Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients
2015 S. Gimondi, A. Cavanè, A. Vendramin, G. Biancon, A. Bermema, V. Montefusco, P. Corradini, C. Carniti
Pharmacologic inhibition of JAK1/JAK2 signaling reduces experimental murine acute GVHD while preserving GVT effects
2015 C. Carniti, S. Gimondi, A. Vendramin, C. Recordati, D. Confalonieri, A. Bermema, P. Corradini, J. Mariotti
The Graft Monocytic Myeloid Derived Suppressor Cells Content Predicts the Risk of Acute Graft versus Host Disease after Allogeneic Transplantation of Granulocyte Colony-Stimulating Factor mobilized Peripheral Blood Stem Cells
2014 A. Vendramin, S. Gimondi, A. Bermema, P. Longoni, S. Rizzitano, P. Corradini, C. Carniti
IDENTIFICAZIONE DI NUOVE VIE DI SEGNALE E MARCATORI PREDITTIVI DELLA MALATTIA DEL TRAPIANTO CONTRO L'OSPITE DOPO TRAPIANTO ALLOGENICO DI CELLULE STAMINALI EMATOPOIETICHE
2014 S.A. Gimondi
A novel method for the detection of minimal residual disease in B-cell malignancies : ion semiconductor sequencing for the evaluation of Igh gene rearrangements
2014 S. Gimondi, A. Cavanè, A. Vendramin, G. Biancon, P. Corradini, C. Carniti